argus

Gland Pharma Limited

NSE: GLANDINE068V0102347,834 Cr

Timeline

Time (IST)TypeMEventSrc
01 Sept, 03:49 pmother1Gland Pharma provides general updates to the exchange with no specific economic event or financial figures disclosed.nse
17 Aug, 01:03 pmGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
17 Aug, 01:01 pmGland Pharma Limited has informed the Exchange about Transcriptnse
14 Aug, 08:44 amGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Managementbse
14 Aug, 08:42 amGland Pharma Limited has informed the Exchange regarding Appointment of Mr Deepak Sapra as Chief Executive Officer of the company w.e.f. November 16, 2026.nse
10 Aug, 09:59 pmGland Pharma Limited has informed the Exchange about Link of Recordingnse
10 Aug, 04:34 pmGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
10 Aug, 04:33 pmGland Pharma Limited has informed the Exchange about Investor Presentationnse
10 Aug, 04:28 pmGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
10 Aug, 04:28 pmGland Pharma Limited has informed the Exchange regarding a press release dated August 10, 2026, titled "Press Release on Q1FY27 Financial Results".nse
10 Aug, 04:23 pmGland Pharma Ltd - 543245 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026bse
10 Aug, 04:20 pmGland Pharma Ltd - 543245 - Unaudited Financial Results For The Quarter Ended June 30, 2026bse
10 Aug, 04:19 pmGland Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
09 Aug, 09:41 amGland Pharma Limited has informed the Exchange regarding a press release dated August 09, 2026, titled "Gland Pharma Announces Strategic CDMO Partnership with aGlobal Pharmaceutical Company".nse
09 Aug, 09:32 amGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
09 Aug, 09:31 amGland Pharma Limited has informed the Exchange about Arrangements for strategic, technical, manufacturing, or marketing tie upnse
05 Aug, 04:03 pmGland Pharma Limited has informed the Exchange regarding a press release dated August 05, 2026, titled "Gland Pharma and Neuland Laboratories Announce Strategic Collaboration for Sterile API Manufacturing".nse
05 Aug, 04:03 pmGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
31 Jul, 08:43 pmGland Pharma Limited has informed the Exchange regarding 'Letter to Shareholders regarding the dispatch of 48th AGM Notice and Annual report for the FY 2025-26'.nse
31 Jul, 08:24 pmGland Pharma Limited has informed the Exchange regarding 'BRSR Report for the year ended March 31, 2026'.nse
31 Jul, 08:21 pmGland Pharma Ltd - 543245 - Reg. 34 (1) Annual Report.bse
30 Jul, 05:32 pmGland Pharma Limited has informed the Exchange regarding 'Allotment of Equity Shares on exercise of ESOPS'.nse
30 Jul, 05:27 pmGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Issue of Securitiesbse
30 Jul, 05:27 pmGland Pharma Limited has informed the Exchange about Options to purchase securitiesnse
29 Jul, 11:38 amGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
29 Jul, 11:37 amGland Pharma Limited has informed the Exchange regarding a press release dated July 29, 2026, titled "Gland Pharma receives approval for Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials".nse
24 Jul, 10:09 pmGland Pharma Ltd - 543245 - Board Meeting Intimation for Declaration Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026bse
20 Jul, 10:54 pmGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
20 Jul, 10:46 pmGland Pharma Limited has informed the Exchange regarding Change in Director(s) of the company.nse
16 Jul, 04:06 pmGland Pharma Ltd - 543245 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
16 Jul, 04:05 pmGland Pharma Limited has informed the Exchange about Action(s) taken or orders passednse
14 Jul, 04:30 pmGland Pharma Ltd - 543245 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
16 Jun, 04:12 pmGland Pharma Limited has informed the Exchange regarding 'General'.nse
16 Jun, 04:12 pmGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Resignation of Directorbse
15 Jun, 05:33 pmGland Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMPnse
15 Jun, 04:50 pmGland Pharma Limited has informed the Exchange regarding Change in Director(s) of the company.nse
15 Jun, 04:48 pmGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Resignation of Directorbse
15 Jun, 04:45 pmGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
15 Jun, 04:41 pmGland Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 15, 2026.nse
02 Jun, 02:15 pmGland Pharma Limited has informed the Exchange regarding 'Allotment of 203259 Equity shares on exercise of Employee Stock Options'.nse
20 May, 05:46 pmGland Pharma Ltd - 543245 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
20 May, 12:17 pmGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
20 May, 12:16 pmGland Pharma Limited has informed the Exchange about Transcriptnse
15 May, 09:14 pmGland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
15 May, 09:14 pmGland Pharma Limited has informed the Exchange about Link of Recordingnse
15 May, 05:48 pmGland Pharma Ltd - 543245 - Grant Of Stock Options Under Gland Pharma Employee Stock Option Scheme 2025bse
15 May, 05:43 pmGland Pharma Limited has informed the Exchange about Options to purchase securitiesnse
15 May, 04:59 pmGland Pharma Limited has informed the Exchange regarding 'The 48th AGM of the Company will be held on August 25, 2026'.nse
15 May, 04:56 pmGland Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 11-Aug-2026.nse
15 May, 04:49 pmGland Pharma Ltd - 543245 - Board Fixes Record Date Of August 11, 2026 For The Final Dividendbse